Ashley Classen, DO
Interventional Pain Medicine · Fort Worth, TXNPI 1629071733
Payments from drug & device makers
Across 473 payments — averaging $90.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$18K
- Genesys Orthopedics Systems, L.L.C.$9K
- Nevro Corp.$4K
- Spinal Simplicity, LLC$2K
- Saluda Medical Americas, Inc.$2K
- Southern Spine, LLC$2K
- plus $7K from 28 others
Across 1 payment — averaging $820.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$820
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 166 | $17,703 |
| Genesys Orthopedics Systems, L.L.C. | 11 | $8,513 |
| Nevro Corp. | 58 | $3,674 |
| Spinal Simplicity, LLC | 30 | $2,081 |
| Saluda Medical Americas, Inc. | 9 | $2,073 |
| Southern Spine, LLC | 1 | $1,700 |
| Vertiflex, Inc. | 46 | $1,640 |
| Boston Scientific | 33 | $1,113 |
| Nalu Medical, Inc. | 22 | $795 |
| Abbott | 15 | $662 |
| Vertos Medical, Inc. | 5 | $475 |
| Globus Medical | 8 | $402 |
| Amgen | 11 | $356 |
| Painteq LLC | 8 | $342 |
| SPR Therapeutics, Inc | 6 | $267 |
| Vyaire Medical, Inc. | 2 | $150 |
| Relievant Medsystems, Inc. | 2 | $130 |
| Pfizer | 7 | $112 |
| Vertex | 4 | $101 |
| Tersera Therapeutics LLC | 4 | $100 |
| MML US, Inc. | 2 | $87 |
| Lundbeck LLC | 4 | $81 |
| GRT US Holding, Inc. | 2 | $71 |
| Si-bone, Inc. | 3 | $63 |
| Forte Bio-pharma LLC | 2 | $47 |
| Hikma Pharmaceuticals USA | 2 | $39 |
| Foundation Fusion Solutions, LLC | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Biogen | 1 | $16 |
| Orexo US, Inc. | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Curonix LLC | 1 | $14 |
How this compares
$42,933 in reported general payments places this provider in the 85th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Fort Worth
- Timothy RatinoFort Worth$139K
- Robert MenziesFort Worth$85K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.2M
- Genaro GutierrezAustin$1.3M
- Chad StephensSouthlake$1.1M
- Ioannis SkaribasHouston$979K
- Duane GriffithTyler$730K
- Brannon FrankAustin$698K
- Robert WillsRound Rock$692K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.